x

Search for a clinical trial

* (*) mandatory field

An Open-Label Study for Previously Treated Ataluren (PTC124) Patients With Nonsense Mutation Dystrophinopathy (Phase III) - DE

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Ongoing trial
  • Funded by an IRDiRC member
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Ptc therapeutics, inc.
  • Website
    • Phase : III
  • Principal investigator of clinical trial

  • Pr Janbernd KIRSCHNER
  • Klinik für Neuropädiatrie und Muskelerkrankungen
  • Zentrum für Kinder- und Jugendmedizin Freiburg
  • Mathildenstr. 1
  • 79106 FREIBURG
  • GERMANY
  • More information
  • Phone  : 49 (0)761 270 43150
  • Fax  : 49 (0)761 270 44750
  • Website
Last update: March 2017

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.